| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |